Sandbox Myopathy: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 5: Line 5:
==Differentiating Various Muscle Weakness==
==Differentiating Various Muscle Weakness==
{| class="wikitable"
{| class="wikitable"
! colspan="4" |Medications
! rowspan="3" |
! colspan="7" |Symptoms
! colspan="2" |Physical Examination
! colspan="5" |Diagnosis
|-
! rowspan="2" |Age of onset
! colspan="2" |Muscle weakness
! rowspan="2" |Fatigue
! rowspan="2" |Myalgia
! rowspan="2" |Cramps
! rowspan="2" |Myoglobinuria
!
! colspan="2" rowspan="2" |
! rowspan="2" |Laboratory Findings
! rowspan="2" |Creatine Kinase
! rowspan="2" |Muscle Biopsy
! rowspan="2" |Electromyogram
|-
!Proximal
!DIstal
!
|-
! colspan="15" |Medications
|-
|-
|Corticosteroids
|Corticosteroids
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 13: Line 46:
|-
|-
|Statins
|Statins
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 18: Line 62:
|-
|-
|Anti-Thyroid  
|Anti-Thyroid  
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 23: Line 78:
|-
|-
|Chemotherapeutic
|Chemotherapeutic
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 28: Line 94:
|-
|-
|Organophosphate intoxication
|Organophosphate intoxication
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 33: Line 110:
|-
|-
|Alcohol
|Alcohol
|Variable
|      '''+'''
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
! colspan="4" |Endocrine  
! colspan="15" |Endocrine  
|-
|-
|Adrenal insufficiency
|Adrenal insufficiency
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 45: Line 144:
|-
|-
|Cushing's disease
|Cushing's disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 50: Line 160:
|-
|-
|Secondary hyperparathyroidism
|Secondary hyperparathyroidism
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 55: Line 176:
|-
|-
|Hyperthyroidism
|Hyperthyroidism
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 60: Line 192:
|-
|-
|Hypothyroidism
|Hypothyroidism
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
! colspan="4" |Inlammatory
! colspan="15" |Inflammatory / Rheumatologic
|-
|-
|Dermatomyositis
|Dermatomyositis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 72: Line 226:
|-
|-
|Polymyositis
|Polymyositis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 77: Line 242:
|-
|-
|Inclusion body myositis
|Inclusion body myositis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
! colspan="4" |Rheumatologic
|Fibomyalgia
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
|Cervical spondylosis
|Polymyalgia Rheumatica
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|Degenerative disc disease
|
|
|
|
|
|
|-
|-
|Spinal cord injury
|Chronic Pain Syndrome
|
|
|
|
|
|
|
|
|-
|Spinal muscle atrophy
|
|
|
|
|
|
|-
|Fibomyalgia
|
|
|
|
|
|
|-
|Polymyalgia Rheumatica
|
|
|
|
|
|
|-
|-
! colspan="4" |Genetic
! colspan="15" |Genetic
|-
|-
|Becker muscular dystrophy
|Becker muscular dystrophy
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 121: Line 324:
|-
|-
|Limb-girdle muscular dystrophies
|Limb-girdle muscular dystrophies
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 126: Line 340:
|-
|-
|Myotonic dystrophy type 1
|Myotonic dystrophy type 1
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
! colspan="4" |Infectious
! colspan="15" |Infectious
|-
|-
|Lyme disease
|Lyme disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 138: Line 374:
|-
|-
|Infulenza
|Infulenza
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 143: Line 390:
|-
|-
|Polio
|Polio
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 148: Line 406:
|-
|-
|Syphilis
|Syphilis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 153: Line 422:
|-
|-
|HIV
|HIV
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
! colspan="4" |Neurologic
! colspan="15" |Neurologic
|-
|-
|ALS
|ALS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 165: Line 456:
|-
|-
|Stroke
|Stroke
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 170: Line 472:
|-
|-
|GBS
|GBS
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 175: Line 488:
|-
|-
|Multiple Sclerosis
|Multiple Sclerosis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
! colspan="4" |Neuro-muscular  
! colspan="15" |Neuro-muscular  
|-
|-
|Botulisim
|Botulisim
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 187: Line 522:
|-
|-
|Lambert-Eaton myaes
|Lambert-Eaton myaes
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 192: Line 538:
|-
|-
|Myasthenia gravis
|Myasthenia gravis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
|-
! colspan="4" |Metabolic
! colspan="15" |Paraneoplastic
|-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|-
! colspan="15" |Metabolic
|-
|-
|Glycogen storage disease
|Glycogen storage disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 204: Line 590:
|-
|-
|Lipid storage disease
|Lipid storage disease
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Line 209: Line 606:
|-
|-
|Mitochondrial
|Mitochondrial
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|}
|}

Revision as of 22:21, 22 March 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Differentiating Various Muscle Weakness

Symptoms Physical Examination Diagnosis
Age of onset Muscle weakness Fatigue Myalgia Cramps Myoglobinuria Laboratory Findings Creatine Kinase Muscle Biopsy Electromyogram
Proximal DIstal
Medications
Corticosteroids
Statins
Anti-Thyroid
Chemotherapeutic
Organophosphate intoxication
Alcohol Variable +
Endocrine
Adrenal insufficiency
Cushing's disease
Secondary hyperparathyroidism
Hyperthyroidism
Hypothyroidism
Inflammatory / Rheumatologic
Dermatomyositis
Polymyositis
Inclusion body myositis
Fibomyalgia
Polymyalgia Rheumatica
Chronic Pain Syndrome
Genetic
Becker muscular dystrophy
Limb-girdle muscular dystrophies
Myotonic dystrophy type 1
Infectious
Lyme disease
Infulenza
Polio
Syphilis
HIV
Neurologic
ALS
Stroke
GBS
Multiple Sclerosis
Neuro-muscular
Botulisim
Lambert-Eaton myaes
Myasthenia gravis
Paraneoplastic
Metabolic
Glycogen storage disease
Lipid storage disease
Mitochondrial
Retrieved from "https://www.wikidoc.org/index.php?title=Sandbox_Myopathy&oldid=1456148"